4 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
#Candidiasis #candida ... mucosal #IDSA #Prevention ... #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
Candida Glabrata
Species of Candida Most Commonly Isolated in Bloodstream Infections
 • Symptomatic mucosal infection is detected
oropharyngeal, esophageal ... candidiasis, in HIV ... antibacterial medications ... Treatment: • Exhibits ... susceptibility testing
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
and Treating Varicella ... Indications: ... health-care provider diagnosis ... #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
prevent TB disease) Indications ... and molecular diagnostic ... Tuberculosis #TB #IDSA #Prevention ... #Treatment #management ... #HIVAIDS #pharmacology